APRE
Aprea Therapeutics, Inc. · Healthcare · Market cap $9.7M(Price slightly stale)
Insider Buying
$61K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Jun 17, 2026
Gilad Oren
Aprea Therapeutics, Inc. (APRE) has 14 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 17, 2026.
Inside the rolling window, 3 insiders at Aprea Therapeutics, Inc. reported 4 open-market purchases totaling $61K and no open-market sales. The most recent open-market filing is a purchase of 28,100 shares by President/CEO Gilad Oren, dated Jan 30, 2026, worth $25K.
- Industry:Biotechnology
- CEO:Oren Gilad
- Employees:8
- HQ:Boston, PA, US
- IPO:2019-10-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
Gilad OrenFirst filing | President/CEO | Purchase | 28,100 | $25K | Feb 2 | +3.0% | SEC ↗ |
| SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | 5,700 | $5K | Feb 2 | +3.0% | SEC ↗ | |
Duey MarcFirst filing | Director | Purchase | 21,459 | $25K | Dec 11 | -18.1% | SEC ↗ |
Hamill John P.First filing | SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | 5,000 | $6K | Dec 11 | -18.1% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does APRE have?
Aprea Therapeutics, Inc. (APRE) has 14 SEC Form 4 filings (14 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Jun 17, 2026.
When was the most recent SEC Form 4 filing for APRE?
The most recent Form 4 filing for APRE on Tracefour is dated Jun 17, 2026.
What is the net insider flow at APRE over the last 6 months?
Over the trailing 180 days, insiders at APRE have net bought $30K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at APRE in the current window?
Inside the rolling window, insiders at APRE bought $61K and sold $0 based on SEC Form 4 filings.
Can I get alerts for APRE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aprea Therapeutics, Inc. (APRE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Aprea Therapeutics, Inc. is in the Healthcare sector.